Last 36.75 INR
Change Today 0.00 / 0.00%
Volume 0.0
MAKR On Other Exchanges
Symbol
Exchange
Mumbai
As of 4:59 AM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

makers laboratories ltd (MAKR) Snapshot

Open
35.10
Previous Close
36.00
Day High
36.90
Day Low
35.05
52 Week High
09/4/14 - 51.05
52 Week Low
02/20/14 - 15.00
Market Cap
180.7M
Average Volume 10 Days
8.5K
EPS TTM
1.21
Shares Outstanding
4.9M
EX-Date
07/29/11
P/E TM
30.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for MAKERS LABORATORIES LTD (MAKR)

Related News

No related news articles were found.

makers laboratories ltd (MAKR) Related Businessweek News

No Related Businessweek News Found

makers laboratories ltd (MAKR) Details

Makers Laboratories Limited engages in the manufacture and sale of pharmaceutical products in India. The company offers products in various general health therapeutic segments, including antibiotic, anti–inflammatory, analgesic, antispasmodic, cough and cold control, cardio-diabetic, anti-allergic, acid regulatory, anthelmintic, topical antibiotic/antimicrobial, neurotonic, anti-anxiety, tranquiliser, anti-malarial, anti-fungal, anti-emetics and anti-nauseants, anti-diarrhoeal, nutritional, injectable, and other specialties. It offers various formulations, including paracetamol, a-ß arteether, chloroquine, nimuselide, anti cough, and amoxicillin under the Duramol, Loroquin, Artemak-AB, Nimuwin, Cofwin, and Exylin brand names. It serves stockists, doctors, and retailers. The company was incorporated in 1984 and is based in Mumbai, India.

158 Employees
Last Reported Date: 05/27/14
Founded in 1984

makers laboratories ltd (MAKR) Top Compensated Officers

Chief Executive Officer, Whole Time Director ...
Total Annual Compensation: 1.7M
General Manager of Quality Assurance and Whol...
Total Annual Compensation: 1.2M
Compensation as of Fiscal Year 2014.

makers laboratories ltd (MAKR) Key Developments

Makers Laboratories Limited Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Makers Laboratories Limited announced unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported net sales/income from operation (net of excise duty) of INR 189.129 million compared with INR 208.676 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 12.742 million compared with INR 13.652 million for the same period a year ago. Profit from ordinary activities before tax was INR 12.930 million compared with INR 13.445 million for the same period a year ago. Net profit was INR 8.299 million or INR 1.69 per basic and diluted share compared with INR 8.501 million or INR 1.73 per basic and diluted share for the same period a year ago. For the six months, the company reported net sales/income from operation (net of excise duty) of INR 358.410 million compared with INR 375.636 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 21.317 million compared with INR 19.937 million for the same period a year ago. Profit from ordinary activities before tax was INR 21.397 million compared with INR 19.280 million for the same period a year ago. Net profit was INR 13.887 million or INR 2.582 per basic and diluted share compared with INR 12.328 million or INR 2.51 per basic and diluted share for the same period a year ago.

Makers Laboratories Limited, Board Meeting, Nov 12, 2014

Makers Laboratories Limited, Board Meeting, Nov 12, 2014. Agenda: To consider quarterly results.

Makers Laboratories Limited Announces Standalone Unaudited Earnings Results for the First Quarter Ended June 30, 2014

Makers Laboratories Limited announced standalone unaudited earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported total income from operations of INR 169.409 million against INR 167.195 million a year ago. Profit from operations before finance cost and exceptional items was INR 9.369 million against INR 7.223 million a year ago. Profit from ordinary activities before tax was INR 8.467 million against INR 5.835 million a year ago. Net profit was INR 5.588 million against INR 3.827 million a year ago. Earnings per basic and diluted share were INR 1.14 against INR 0.78 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MAKR:IN 36.75 INR 0.00

MAKR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MAKR.
View Industry Companies
 

Industry Analysis

MAKR

Industry Average

Valuation MAKR Industry Range
Price/Earnings 23.0x
Price/Sales 0.3x
Price/Book 0.7x
Price/Cash Flow 8.6x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAKERS LABORATORIES LTD, please visit www.makerslabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.